HOUSTON, May 14, 2026 /PRNewswire/ -- Elabscience® Bionovation Inc. ("Elabscience®" or "the Company") today announced the launch of its self-developed PolyHRP-Streptavidin conjugate, a signal amplification reagent designed to improve enzyme-linked immunosorbent assay (ELISA) sensitivity for low-abundance biomarker detection. Using proprietary covalent polymerization technology, the reagent creates a one-to-many amplification structure that strengthens detection signals while maintaining low background interference.
Elabscience® developed its PolyHRP-Streptavidin conjugate to address a common ELISA challenge in which very low biomarker concentrations can make it difficult to increase signal output without also raising background noise. The product is built on a proprietary covalent coupling technique designed to create a more efficient amplification structure than traditional Streptavidin-HRP conjugates. In this process, a large number of highly active HRP enzymes are first polymerized to form a PolyHRP backbone, which is then conjugated to streptavidin. This one-to-many architecture increases the enzyme-to-protein ratio and enables cascade signal amplification which helps to improve assay sensitivity in low-abundance biomarker detection.
Dr. Yang Fei, General Manager of Elabscience®, commented: "Sensitivity and stability are critical requirements in ELISA reagent development, especially when researchers are working with low-abundance targets. With our self-developed PolyHRP-Streptavidin conjugate, we aim to provide researchers and assay developers with a reliable signal amplification tool that supports stronger detection performance, lower background interference and long-term reagent stability."
Validation data showed strong performance across several key measures. SEC-HPLC analysis of three independent batches demonstrated an approximately 90% product recovery rate, with a peak area coefficient of variation of 2.9%, indicating high batch-to-batch consistency. Nanoparticle tracking analysis also showed a narrow particle size distribution centered at about 155 nm which supports the uniformity of the PolyHRP-Streptavidin polymer structure.
In internal performance testing, Elabscience® PolyHRP-Streptavidin delivered strong signal intensity while maintaining low background signal. Accelerated stability testing at 37°C showed over 90% remaining activity after 11 days, demonstrating strong reagent stability under accelerated conditions. The product is also designed for broad compatibility across standard ELISA, high-sensitivity ELISA and competitive ELISA workflows.
The launch introduces Elabscience® PolyHRP-Streptavidin conjugate, Catalog No. E-ELIR-020, as a specialized ELISA accessory reagent within the Company's signal amplification portfolio. It is available in a 50 μL trial size, a 250 μL catalog format, and custom volumes above 1 mL. The product is stored at -20°C and has a shelf life of two years. Elabscience® also plans to introduce a ready-to-use PolyHRP-Streptavidin detection reagent to further support routine and high-throughput ELISA applications.
About Elabscience® Bionovation Inc.
Elabscience® Bionovation Inc. is a biotechnology company focused on the design, development, manufacturing, and sale of research reagents and services for cell detection and life sciences applications. Its portfolio includes products for protein detection, immunoassays, metabolism analysis, and cell function research. Founded in 2011, Elabscience® serves customers in more than 150 countries and regions. For more information, please visit www.elabscience.com, and connect with us on LinkedIn, YouTube, Facebook and Instagram.
Contact Information:
Elabscience® Bionovation Inc
info@elabscience.com
1-888-852-8623
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Elabscience® Launches Self-Developed PolyHRP-Streptavidin Conjugate for Low-Abundance Biomarker Detection in ELISA
|
XI'AN, China, May 13, 2026 /PRNewswire/ -- At Vitafoods Europe 2026, Natural Field drew significant industry attention with the presentation of its NFco-Loading® liposomal technology platform and a science-backed healthy aging solution designed for next-generation nutraceutical formulations.
As global demand for healthy aging products continues to accelerate, Natural Field emphasized a key industry challenge during the exhibition: many active ingredients face limitations in stability, absorption efficiency, and formulation compatibility when used in conventional delivery formats.
To address these challenges, the company introduced its proprietary NFco-Loading® technology — an advanced co-loading liposomal delivery platform engineered to encapsulate multiple active ingredients within a single liposomal system. The platform is designed to support enhanced bioavailability, improved ingredient stability, and synergistic formulation performance for complex wellness applications.
A major highlight at the exhibition was NF TriSolve®, Natural Field's advanced healthy aging formulation developed using NFco-Loading® technology. The formulation strategically combines multiple active compounds through co-loading liposomal systems, with a focus on co-loaded Coenzyme Q10 liposomes and co-loaded NMN liposomes — two key components designed to support cellular energy metabolism and combat age-related functional decline. Complemented by ergothioneine and sialic acid, NF TriSolve® demonstrated remarkable effects in zebrafish studies, showing significant improvements in anti-aging markers, enhanced skin radiance, and superior hydration performance. This data underscores the capability of NFco-Loading® technology to deliver multiple actives simultaneously, enabling synergistic benefits for advanced wellness, beauty-from-within, and healthy aging applications.
Rather than focusing solely on individual ingredients, Natural Field's strategy centers on building technology-driven delivery systems capable of improving the functional performance of nutraceutical formulations.
"Consumers are no longer only looking for ingredients — they are looking for efficient delivery, synergistic functionality, and science-backed solutions," said the Natural Field team during Vitafoods Europe 2026. "We believe NFco-Loading® technology represents an important direction for the future of healthy aging innovation."
About Natural Field
Natural Field is a technology-focused ingredient company specializing in liposomal delivery systems and functional nutraceutical ingredients. The company provides one-stop formulation and delivery solutions for global nutraceutical brands, with ongoing research focused on bioavailability enhancement, healthy aging innovation, and advanced lipid-based delivery technologies. For more data, please visit www.natural-field.com.
XI'AN, China, May 13, 2026 /PRNewswire/ -- At Vitafoods Europe 2026, Natural Field drew significant industry attention with the presentation of its NFco-Loading® liposomal technology platform and a science-backed healthy aging solution designed for next-generation nutraceutical formulations.
As global demand for healthy aging products continues to accelerate, Natural Field emphasized a key industry challenge during the exhibition: many active ingredients face limitations in stability, absorption efficiency, and formulation compatibility when used in conventional delivery formats.
To address these challenges, the company introduced its proprietary NFco-Loading® technology — an advanced co-loading liposomal delivery platform engineered to encapsulate multiple active ingredients within a single liposomal system. The platform is designed to support enhanced bioavailability, improved ingredient stability, and synergistic formulation performance for complex wellness applications.
A major highlight at the exhibition was NF TriSolve®, Natural Field's advanced healthy aging formulation developed using NFco-Loading® technology. The formulation strategically combines multiple active compounds through co-loading liposomal systems, with a focus on co-loaded Coenzyme Q10 liposomes and co-loaded NMN liposomes — two key components designed to support cellular energy metabolism and combat age-related functional decline. Complemented by ergothioneine and sialic acid, NF TriSolve® demonstrated remarkable effects in zebrafish studies, showing significant improvements in anti-aging markers, enhanced skin radiance, and superior hydration performance. This data underscores the capability of NFco-Loading® technology to deliver multiple actives simultaneously, enabling synergistic benefits for advanced wellness, beauty-from-within, and healthy aging applications.
Rather than focusing solely on individual ingredients, Natural Field's strategy centers on building technology-driven delivery systems capable of improving the functional performance of nutraceutical formulations.
"Consumers are no longer only looking for ingredients — they are looking for efficient delivery, synergistic functionality, and science-backed solutions," said the Natural Field team during Vitafoods Europe 2026. "We believe NFco-Loading® technology represents an important direction for the future of healthy aging innovation."
About Natural Field
Natural Field is a technology-focused ingredient company specializing in liposomal delivery systems and functional nutraceutical ingredients. The company provides one-stop formulation and delivery solutions for global nutraceutical brands, with ongoing research focused on bioavailability enhancement, healthy aging innovation, and advanced lipid-based delivery technologies. For more data, please visit www.natural-field.com.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Natural Field Showcases NFco-Loading® Healthy Aging Solution at Vitafoods Europe 2026
